Page 5 - Affinity Technologies News Today

BioAffinity Technologies (NASDAQ:BIAF – Get Free Report) and Guardant Health (NASDAQ:GH – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership and risk. Institutional & Insider Ownership 1.1% of bioAffinity Technologies […]

14.11.2023 - bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three and nine months ...

BioAffinity Technologies, Inc. announced the appointment of Dallas J. Coleman as National Director of Sales. Mr. Coleman has more than 15 years of experience in medical sales and marketing, most...

CEO Maria Zannes to hold one-on-one investor meetings and present a corporate update highlighting commercial strategy ...

BioAffinity Technologies (NASDAQ:BIAF – Get Free Report) and Starpharma (OTCMKTS:SPHRY – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership and dividends. Profitability This table compares bioAffinity Technologies and Starpharma’s […]

Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2 million and $0.7 million respectively.

Regulus Therapeutics stock increased by 12.4% to $1.45 during Thursday's after-market session. The company's market cap stands at $28.2 million. • SeqLL…

Dublin, Sept. 19, 2023 (GLOBE NEWSWIRE) -- The

BioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) was the target of a significant decline in short interest during the month of August. As of August 15th, there was short interest totalling 2,100 shares, a decline of 25.0% from the July 31st total of 2,800 shares. Based on an average daily trading volume, of 1,600 […]

SAN ANTONIO--(BUSINESS WIRE)--#BIAF--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three and six months ended June 30, 2023, and provided a...